[{"address1": "7707 Gateway Boulevard", "address2": "Suite 140", "city": "Newark", "state": "CA", "zip": "94560-1160", "country": "United States", "phone": "510 474 0170", "website": "https://www.protagonist-inc.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide-based drugs for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide (PTG-300), an injectable hepcidin mimetic that completed phase 2 clinical trials for the treatment of polycythemia vera and other blood disorders; and JNJ-2113, an orally delivered investigational drug to block biological pathways that completed phase 2b clinical trials for the treatment of moderate-to-severe plaque psoriasis; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company has a license and collaboration agreement with Takeda to commercialize rusfertide; and JNJ Innovative Medicines to co-develop Interleukin-23 receptor antagonist compound JNJ-2113. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.", "fullTimeEmployees": 126, "companyOfficers": [{"maxAge": 1, "name": "Dr. Dinesh V. Patel Ph.D.", "age": 67, "title": "CEO, President, Secretary & Director", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 1026472, "exercisedValue": 0, "unexercisedValue": 10583697}, {"maxAge": 1, "name": "Mr. Asif  Ali", "age": 50, "title": "Executive VP & Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 631042, "exercisedValue": 0, "unexercisedValue": 285755}, {"maxAge": 1, "name": "Dr. Suneel K. Gupta Ph.D.", "age": 65, "title": "Executive VP of Clinical Development", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 719206, "exercisedValue": 0, "unexercisedValue": 2986052}, {"maxAge": 1, "name": "Mr. Mohammad  Masjedizadeh Ph.D.", "title": "Executive VP & Chief Technical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Newman  Yeilding", "title": "EVP, Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew M. Gosling J.D.", "age": 53, "title": "Executive VP & General Counsel", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Carena  Spivey", "title": "Head of HR & Senior VP of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ashok  Bhandari Ph.D.", "age": 60, "title": "Executive VP & Chief Drug Discovery and Preclinical Development Officer", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Carter J. King", "age": 53, "title": "Executive Vice President of Business Development", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Abha  Bommireddi", "title": "Executive Vice President of Portfolio & Program Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 7, "overallRisk": 8, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 38.49, "open": 39.6, "dayLow": 38.435, "dayHigh": 39.9, "regularMarketPreviousClose": 38.49, "regularMarketOpen": 39.6, "regularMarketDayLow": 38.435, "regularMarketDayHigh": 39.9, "payoutRatio": 0.0, "beta": 2.213, "trailingPE": 14.142336, "forwardPE": -27.097902, "volume": 597849, "regularMarketVolume": 583973, "averageVolume": 615447, "averageVolume10days": 563070, "averageDailyVolume10Day": 563070, "bid": 38.61, "ask": 39.06, "bidSize": 4, "askSize": 4, "marketCap": 2309422592, "fiftyTwoWeekLow": 24.22, "fiftyTwoWeekHigh": 48.89, "priceToSalesTrailing12Months": 7.13236, "fiftyDayAverage": 38.7026, "twoHundredDayAverage": 39.1623, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1836106752, "profitMargins": 0.52765, "floatShares": 47504984, "sharesOutstanding": 59598000, "sharesShort": 3793117, "sharesShortPriorMonth": 3798682, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0636, "heldPercentInsiders": 0.019, "heldPercentInstitutions": 1.08554, "shortRatio": 6.91, "shortPercentOfFloat": 0.0645, "impliedSharesOutstanding": 59598000, "bookValue": 8.936, "priceToBook": 4.3363924, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": 170848992, "trailingEps": 2.74, "forwardEps": -1.43, "enterpriseToRevenue": 5.671, "enterpriseToEbitda": 12.235, "52WeekChange": 0.35147476, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 38.75, "targetHighPrice": 68.0, "targetLowPrice": 43.0, "targetMeanPrice": 58.4, "targetMedianPrice": 59.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 10, "totalCash": 468720992, "totalCashPerShare": 7.865, "ebitda": 150068000, "totalDebt": 10900000, "quickRatio": 10.574, "currentRatio": 10.695, "totalRevenue": 323795008, "debtToEquity": 2.049, "revenuePerShare": 5.3, "returnOnAssets": 0.19959, "returnOnEquity": 0.40967998, "grossProfits": 323795008, "freeCashflow": 144935008, "operatingCashflow": 230290000, "grossMargins": 1.0, "ebitdaMargins": 0.46347, "operatingMargins": -8.86695, "financialCurrency": "USD", "symbol": "PTGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1740172134, "regularMarketTime": 1740171600, "exchange": "NGM", "messageBoardId": "finmb_129263324", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.67549574, "regularMarketPrice": 38.75, "shortName": "Protagonist Therapeutics, Inc.", "longName": "Protagonist Therapeutics, Inc.", "marketState": "POST", "priceEpsCurrentYear": -46.92931, "fiftyDayAverageChange": 0.04740143, "fiftyDayAverageChangePercent": 0.0012247609, "twoHundredDayAverageChange": -0.4123001, "twoHundredDayAverageChangePercent": -0.010527985, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1470922200000, "postMarketChangePercent": -2.8645177, "postMarketPrice": 37.64, "postMarketChange": -1.1100006, "regularMarketChange": 0.25999832, "regularMarketDayRange": "38.435 - 39.9", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 615447, "fiftyTwoWeekLowChange": 14.530001, "fiftyTwoWeekLowChangePercent": 0.5999175, "fiftyTwoWeekRange": "24.22 - 48.89", "fiftyTwoWeekHighChange": -10.139999, "fiftyTwoWeekHighChangePercent": -0.20740436, "fiftyTwoWeekChangePercent": 35.147476, "earningsTimestamp": 1740144600, "earningsTimestampStart": 1740144600, "earningsTimestampEnd": 1740144600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 2.74, "epsForward": -1.43, "epsCurrentYear": -0.82571, "displayName": "Protagonist Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]